OMERS Capital Markets Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Investments

Industry

Estimated Revenue & Valuation

  • OMERS Capital Markets's estimated annual revenue is currently $24.5M per year.(i)
  • OMERS Capital Markets's estimated revenue per employee is $266,478

Employee Data

  • OMERS Capital Markets has 92 Employees.(i)
  • OMERS Capital Markets grew their employee count by -8% last year.

OMERS Capital Markets's People

NameTitleEmail/Phone
1
Director/Portfolio ManagerReveal Email/Phone
2
Director, Data & Analytics DeliveryReveal Email/Phone
3
Director, Cross Asset StrategiesReveal Email/Phone
4
Derivatives TraderReveal Email/Phone
5
Executive AssistantReveal Email/Phone
6
Business AnalystReveal Email/Phone
7
Multi-Asset Derivative TradingReveal Email/Phone
8
Trading AnalystReveal Email/Phone
9
Analyst, Global Multi-Asset StrategiesReveal Email/Phone
10
Investment AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$352.4M1012-1%N/AN/A
#2
$863.5M27319%N/AN/A
#3
$1.8M1330%N/AN/A
#4
$49.2M1977%N/AN/A
#5
$134.2M4732%N/AN/A
#6
$155.7M2283%N/AN/A
#7
$2.5M14-18%N/AN/A
#8
$17.7M7839%N/AN/A
#9
$3.5M215%N/AN/A
#10
$0.8M170%N/AN/A
Add Company

What Is OMERS Capital Markets?

OMERS Capital Markets invests in companies with strong balance sheets and resilient business models. We partner with leading businesses, operators, and best-in-class investors to pursue traditional and innovative investment opportunities across the globe.

keywords:N/A

N/A

Total Funding

92

Number of Employees

$24.5M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

OMERS Capital Markets News

2022-04-19 - Planning for Uncertainty: Pharma CFO Anthony Doyle

In 2014, it brought to market Peramivir, an influenza treatment. ... deal with Royalty Pharma and OMERS Capital Markets [the Canadian public...

2022-04-19 - Planning for Uncertainty: Pharma CFO Anthony Doyle

In 2014, it brought to market Peramivir, an influenza treatment. ... deal with Royalty Pharma and OMERS Capital Markets [the Canadian public...

2022-04-13 - OEP already closed 12 platform deals out of new $2.75bn fund ...

Founded in 2011, Dyal Capital is today the market's largest GP stakes investor. Last spring, Dyal merged with Owl Rock Capital Partners,...

2022-04-13 - OEP already closed 12 platform deals out of new $2.75bn fund ...

Founded in 2011, Dyal Capital is today the market's largest GP stakes investor. Last spring, Dyal merged with Owl Rock Capital Partners,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16M9244%N/A
#2
$17M92-11%N/A
#3
$7.5M9218%N/A
#4
$25.9M9214%N/A
#5
$22.4M9210%N/A